Atai Life Sciences N.V. (ATAI) is currently Overvalued by 301.22%

Atai Life Sciences N.V. (ATAI) appears overvalued by approximately 301.22% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

Downside (live) 301.22% (from live valuation API)
Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$5.19

Stock valuation checker

Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.

Explore Our Valuation Calculators

Intrinsic Value Calculator (DCF)ROE Calculator Stock Valuation Calculator

Why is Atai Life Sciences N.V. overvalued or undervalued?

Based on intrinsic value, Atai Life Sciences N.V. (ATAI) looks priced with a margin of safety relative to a cash-flow-based fair value that blends growth, reinvestment needs, and a risk-adjusted discount rate.

Compared to historical valuation, today’s multiple sits under the range implied by the company’s own five-year average—suggesting the market is more cautious than its own past pricing of similar fundamentals.

Market expectations embedded in the price imply a modest bar for execution: revenue cadence, margin stability, and capital returns would need to hold up to justify a sustained discount versus fair value.

Key metrics

P/E ratio: 8.3x
Revenue growth (TTM y/y): 9%
Profit margin: 17.5%
Fair value (model): Unlock

Next steps

Frequently asked questions — ATAI

Is ATAI overvalued right now?

Based on our 2026 models, Atai Life Sciences N.V. (ATAI) appears overvalued at $5.19 with roughly 301.2% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Atai Life Sciences N.V.'s intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether ATAI trades above or below fair value. At $5.19, Atai Life Sciences N.V. currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Atai Life Sciences N.V.'s intrinsic value calculated?

Tickerplace calculates ATAI's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is ATAI undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether ATAI's gap aligns with fundamentals using the ratios and financial links on this page.

Peers for ATAI: open their overvalued / undervalued view.

Instant valuation answer